Synthesis of doxorubicin-PLGA loaded chitosan stabilized (Mn, Zn)Fe 2 O 4 nanoparticles: Biological activity and pH-responsive drug release

Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity

“…Over the last two years, the main anticancer drug coupled to IONPs was doxorubicin (DOX) [ 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 ]. This drug can be covalently bound to functionalized IONPs [ 123 ] or establish electrostatic interactions with negatively charged groups present in the magnetic nanocarriers [ 133 ].…”

Copper Immobilized on Isonicotinic Acid Hydrazide Functionalized Nano‐Magnetite as a Novel Recyclable Catalyst for Direct Synthesis of Phenols and Anilines

“…Isonicotinic acid hydrazide (INH) has been used as an antibiotic for the treatment of tuberculosis and in making optical sensors ,. Recently, the delivery of therapeutic drugs such as INH by magnetic nanoparticles has been reported ,. Phenol and aniline derivatives are very significant due to their properties and activity in synthetic chemistry, natural products, pharmaceuticals chemistry, polymers, agrochemicals and industrial chemistry .…”

Development of doxorubicin loading platform based albumin-sporopollenin as drug carrier

“…Drugs based on proteins, peptides and oligonucleotides tend to attract the greatest attention at present due to their potential to treat chronic diseases [1] . The research is centered on overcoming the main obstacle to the treatment of cancer by chemotherapy, i.e., the destruction of healthy tissue by the therapeutic agents [2] . Biocompatible polymeric based particles ( BPs ) as effective delivery carriers of drugs has received considerable attention in recent years because they possess the ability to deliver drugs to varied areas of the body for sustained periods of time [3] , [4] , [5] , [6] .…”

“…The research is centered on overcoming the main obstacle to the treatment of cancer by chemotherapy, i.e., the destruction of healthy tissue by the therapeutic agents [2] . Biocompatible polymeric based particles ( BPs ) as effective delivery carriers of drugs has received considerable attention in recent years because they possess the ability to deliver drugs to varied areas of the body for sustained periods of time [3] , [4] , [5] , [6] . Biological polymers with several properties such as good biological compatibility, nontoxicity and high hydrophilicity, comparing with synthetic organic materials when used as drug carriers [5] , [6] , [7] , [8] , [9] .…”

“…Biocompatible polymeric based particles ( BPs ) as effective delivery carriers of drugs has received considerable attention in recent years because they possess the ability to deliver drugs to varied areas of the body for sustained periods of time [3] , [4] , [5] , [6] . Biological polymers with several properties such as good biological compatibility, nontoxicity and high hydrophilicity, comparing with synthetic organic materials when used as drug carriers [5] , [6] , [7] , [8] , [9] . Suitable modification and optimization of the form of the biological polymer has to be determined to properly target the selected polymer and its controlled release to the affected organs [10] , [11] .…”